GlassScriptPhysician profile
John C Jaques
NPI 1073581435
$1,024.30
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $943 · 2022: $67.93 · 2023: $13.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $154.56 | 2021 | |
| Nevro Corp. | $123.67 | 2021 | |
| Eisai INC. | $100.15 | 2021 | |
| Abbvie INC. | $97.38 | 2021-2022 | |
| Forte Bio-Pharma LLC | $79.19 | 2021 | |
| Boston Scientific Corporation | $70.67 | 2021-2023 | Wavewriter Alpha Prime 16 |
| Novartis Pharmaceuticals Corporation | $62.50 | 2021 | |
| Radius Health, INC. | $47.20 | 2021 | |
| Arbor Pharmaceuticals, INC. | $36.39 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $24.92 | 2021 | |
| Alfasigma USA, INC. | $21.92 | 2021 | |
| Fidia Pharma USA INC. | $17.98 | 2021 | |
| Abbott Laboratories | $17.68 | 2021 | |
| Lilly USA, LLC | $16.94 | 2021 | |
| Relievant Medsystems, INC. | $16.88 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $16.82 | 2021 | |
| Horizon Therapeutics Plc | $16.46 | 2021 | |
| Acacia Pharma INC | $16.38 | 2021 | |
| Grt US Holding, INC. | $16.35 | 2021 | |
| Ibsa Pharma INC. | $15.86 | 2021 | |
| Amgen INC. | $15.75 | 2021 | |
| Baudax Bio INC. | $14.48 | 2021 | |
| Biodelivery Sciences International, INC. | $12.43 | 2021 | |
| Stimwave Technologies Incorporated | $11.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Jaques listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.